Method of stabilizing a bioactive peptide against protease hydrolysis

US10947290B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10947290-B2
Application numberUS-201816209128-A
CountryUS
Kind codeB2
Filing dateDec 4, 2018
Priority dateApr 28, 2014
Publication dateMar 16, 2021
Grant dateMar 16, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention includes a thioamide-modified peptide, wherein the thioamide modification increases the in vivo half-life of the peptide. The invention further includes methods of treating or preventing a disease or disorder in a subject in need thereof, the method comprising administering to the subject a thioamide-modified peptide of the invention.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of stabilizing a bioactive peptide against protease hydrolysis, the method comprising replacing the amide bond formed between the first and second amino acid residues from the N-terminus of the bioactive peptide with a thioamide bond, wherein the protease comprises at least one selected from the group consisting of DPP-4 and carboxypeptidase. 2. The method of claim 1 , wherein the bioactive peptide comprises at least one selected from the group consisting of GIP, OCM, GLP-1, NPY, GHRH, ENT, and BNP. 3. The method of claim 1 , wherein the thioamide-modified peptide has equivalent biological activity or longer in vivo half-life to the bioactive peptide.

Assignees

Inventors

Classifications

  • Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00) · CPC title

  • Glucagons · CPC title

  • by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents · CPC title

  • C07K14/605Primary

    Glucagons · CPC title

  • Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10947290B2 cover?
The invention includes a thioamide-modified peptide, wherein the thioamide modification increases the in vivo half-life of the peptide. The invention further includes methods of treating or preventing a disease or disorder in a subject in need thereof, the method comprising administering to the subject a thioamide-modified peptide of the invention.
Who is the assignee on this patent?
Univ Pennsylvania, Harvard College
What technology area does this patent fall under?
Primary CPC classification C07K14/605. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Mar 16 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).